Experiment: 2MZE

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.4 mM [U-100% 13C; U-100% 15N] proMMP-7(E195A), 20 mM imidazole, pH 6.6, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide	90% H2O/10% D2O		6.6		310
2	2D 1H-13C HSQC	0.4 mM [U-100% 13C; U-100% 15N] proMMP-7(E195A), 20 mM imidazole, pH 6.6, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide	90% H2O/10% D2O		6.6		310
3	3D HNCACB	0.4 mM [U-100% 13C; U-100% 15N] proMMP-7(E195A), 20 mM imidazole, pH 6.6, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide	90% H2O/10% D2O		6.6		310
4	3D CBCA(CO)NH	0.4 mM [U-100% 13C; U-100% 15N] proMMP-7(E195A), 20 mM imidazole, pH 6.6, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide	90% H2O/10% D2O		6.6		310
5	3D HNCO	0.4 mM [U-100% 13C; U-100% 15N] proMMP-7(E195A), 20 mM imidazole, pH 6.6, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide	90% H2O/10% D2O		6.6		310
6	3D HNCA	0.4 mM [U-100% 13C; U-100% 15N] proMMP-7(E195A), 20 mM imidazole, pH 6.6, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide	90% H2O/10% D2O		6.6		310
7	3D HN(CO)CA	0.4 mM [U-100% 13C; U-100% 15N] proMMP-7(E195A), 20 mM imidazole, pH 6.6, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide	90% H2O/10% D2O		6.6		310
8	2D 1H-13C HSQC aromatic	0.4 mM [U-100% 13C; U-100% 15N] proMMP-7(E195A), 20 mM imidazole, pH 6.6, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide	90% H2O/10% D2O		6.6		310
9	3D H(CCO)NH	0.4 mM [U-100% 13C; U-100% 15N] proMMP-7(E195A), 20 mM imidazole, pH 6.6, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide	90% H2O/10% D2O		6.6		310
10	3D HCCH-TOCSY	0.4 mM [U-100% 13C; U-100% 15N] proMMP-7(E195A), 20 mM imidazole, pH 6.6, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide	90% H2O/10% D2O		6.6		310
11	(Hb)Cb(CgCd)Hd	0.4 mM [U-100% 13C; U-100% 15N] proMMP-7(E195A), 20 mM imidazole, pH 6.6, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide	90% H2O/10% D2O		6.6		310
12	(Hb)Cb(CgCd)He	0.4 mM [U-100% 13C; U-100% 15N] proMMP-7(E195A), 20 mM imidazole, pH 6.6, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide	90% H2O/10% D2O		6.6		310
13	2D 1H-13C HSQC	0.4 mM [U-10% 13C; U-100% 15N] proMMP-7(E195A), 20 mM imidazole, pH 6.6, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide	90% H2O/10% D2O		6.6		310
14	3D 1H-15N NOESY	0.4 mM [U-100% 13C; U-100% 15N] proMMP-7(E195A), 20 mM imidazole, pH 6.6, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide	90% H2O/10% D2O		6.6		310
15	3D 1H-13C NOESY	0.4 mM [U-100% 13C; U-100% 15N] proMMP-7(E195A), 20 mM imidazole, pH 6.6, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide	90% H2O/10% D2O		6.6		310
16	2D 1H-13C HSQC aromatic	0.4 mM [U-100% 13C; U-100% 15N] proMMP-7(E195A), 20 mM imidazole, pH 6.6, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide	90% H2O/10% D2O		6.6		310
17	3D 1H-15N NOESY	0.4 mM [U-100% 15N, U-100% 13CH3 (ILV)] proMMP-7(E195A), 20 mM imidazole, pH 6.6, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide	90% H2O/10% D2O		6.6		310
18	3D 1H-13C NOESY	0.4 mM [U-100% 15N, U-100% 13CH3 (ILV)] proMMP-7(E195A), 20 mM imidazole, pH 6.6, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide	90% H2O/10% D2O		6.6		310

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	800

NMR Refinement
Method	Details	Software
simulated annealing, torsion angle dynamics		TopSpin

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin	3.1	Bruker Biospin
2	processing	TopSpin	3.1	Bruker Biospin
3	peak picking	Analysis	2.4	CCPN
4	chemical shift assignment	Analysis	2.4	CCPN
5	geometry optimization	TALOS		Cornilescu, Delaglio and Bax
6	structure solution	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
7	validation	PSVS		Bhattacharya and Montelione
8	refinement	CYANA

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.